Free Trial

Nuwellis (NUWE) Competitors

Nuwellis logo
$1.31 +0.02 (+1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$1.31 0.00 (0.00%)
As of 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NUWE vs. NXGL, DRIO, CODX, PTHL, NRXS, NEPH, LFWD, PETV, BSGM, and ALUR

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include NEXGEL (NXGL), DarioHealth (DRIO), Co-Diagnostics (CODX), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), NeurAxis (NRXS), Nephros (NEPH), ReWalk Robotics (LFWD), PetVivo (PETV), BioSig Technologies (BSGM), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

Nuwellis vs.

Nuwellis (NASDAQ:NUWE) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, community ranking, profitability, dividends and earnings.

NEXGEL has lower revenue, but higher earnings than Nuwellis. NEXGEL is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$8.86M0.65-$20.21M-$116.41-0.01
NEXGEL$4.09M6.01-$3.16M-$0.58-6.24

NEXGEL has a net margin of -52.60% compared to Nuwellis' net margin of -169.54%. NEXGEL's return on equity of -71.19% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-169.54% -28,159.25% -207.24%
NEXGEL -52.60%-71.19%-34.79%

3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 2.2% of NEXGEL shares are owned by institutional investors. 2.6% of Nuwellis shares are owned by insiders. Comparatively, 24.9% of NEXGEL shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nuwellis has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

In the previous week, NEXGEL had 2 more articles in the media than Nuwellis. MarketBeat recorded 5 mentions for NEXGEL and 3 mentions for Nuwellis. Nuwellis' average media sentiment score of -0.08 beat NEXGEL's score of -0.40 indicating that Nuwellis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nuwellis
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NEXGEL
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nuwellis received 21 more outperform votes than NEXGEL when rated by MarketBeat users. Likewise, 53.66% of users gave Nuwellis an outperform vote while only 50.00% of users gave NEXGEL an outperform vote.

CompanyUnderperformOutperform
NuwellisOutperform Votes
22
53.66%
Underperform Votes
19
46.34%
NEXGELOutperform Votes
1
50.00%
Underperform Votes
1
50.00%

Nuwellis presently has a consensus price target of $17.00, suggesting a potential upside of 1,197.71%. Given Nuwellis' stronger consensus rating and higher possible upside, research analysts clearly believe Nuwellis is more favorable than NEXGEL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuwellis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Nuwellis beats NEXGEL on 10 of the 19 factors compared between the two stocks.

Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUWE vs. The Competition

MetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$5.73M$3.33B$5.77B$9.20B
Dividend YieldN/A1.58%5.25%3.99%
P/E Ratio-0.0118.4526.4419.50
Price / Sales0.6565.01455.0572.31
Price / CashN/A44.0546.0638.90
Price / Book0.073.897.255.07
Net Income-$20.21M$90.91M$3.19B$222.54M
7 Day Performance6.50%4.09%2.14%2.29%
1 Month Performance8.26%2.40%3.49%1.63%
1 Year Performance-93.79%12.08%21.19%16.61%

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUWE
Nuwellis
2.2425 of 5 stars
$1.31
+1.6%
$17.00
+1,197.7%
-93.9%$5.73M$8.86M-0.0170News Coverage
Gap Up
NXGL
NEXGEL
0.6538 of 5 stars
$3.25
-1.8%
N/A+65.0%$22.07M$4.09M-5.6010Short Interest ↑
DRIO
DarioHealth
2.82 of 5 stars
$0.64
-7.0%
$2.50
+290.6%
-70.2%$21.83M$20.35M-0.68200Short Interest ↓
Gap Up
CODX
Co-Diagnostics
3.9068 of 5 stars
$0.68
-1.7%
$1.50
+121.9%
-40.5%$21.59M$6.81M-0.49100
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/A$2.82
+3.3%
N/AN/A$18.56MN/A0.0011
NRXS
NeurAxis
N/A$2.56
+0.4%
N/A-34.7%$18.38M$2.46M-1.3919
NEPH
Nephros
3.0682 of 5 stars
$1.60
+1.3%
$5.00
+213.5%
-56.7%$16.81M$14.24M-17.7230High Trading Volume
LFWD
ReWalk Robotics
3.0979 of 5 stars
$1.87
+33.6%
$11.50
+515.0%
-65.8%$16.47M$25.00M-0.7560Upcoming Earnings
Short Interest ↑
Gap Up
High Trading Volume
PETV
PetVivo
N/A$0.74
-1.7%
N/A-40.5%$16.05M$1.05M-1.5420Gap Down
BSGM
BioSig Technologies
1.6143 of 5 stars
$0.88
-3.6%
$2.75
+213.9%
+51.5%$15.11M$20,000.000.0050
ALUR
Allurion Technologies
2.302 of 5 stars
$5.58
-7.6%
$54.17
+870.7%
-92.7%$14.45M$53.47M-0.47501Gap Down

Related Companies and Tools


This page (NASDAQ:NUWE) was last updated on 2/18/2025 by MarketBeat.com Staff
From Our Partners